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Abstract
Background: The extracellular signal-regulated kinase (ERK) signaling pathway is considered to be associated with
the pathogenesis and treatment of depression. Acupuncture has been demonstrated to ameliorate depression-
related behavior and promote neurogenesis. In this study, we explored the role of the ERK signaling pathway in the
antidepressant-like effects of acupuncture in rats exposed to chronic unpredictable mild stress (CUMS).
Methods: Eighty male Sprague–Dawley rats were randomly divided into eight groups: control group, model
group, model + Acupuncture group (Acu group), model + fluoxetine group (FLX group), model + DMSO group
(DMSO group), model + PD98059 group (PD group), model + Acupuncture + PD98059 group (Acu + PD group)
and model + fluoxetine + PD98059 group (FLX + PD group). Except for the control group, all rats were
subjected to 3 weeks of CUMS protocols to induce depression. Acupuncture was carried out for 10 min at
acupoints of Baihui (GV-20) and Yintang (GV-29) each day during the experimental procedure. The ERK
signaling pathway was inhibited using PD98059 through intracerebroventricular injection. The depression-like
behaviors were evaluated using the sucrose intake and open-field tests. The protein levels of ERK1/2,
phosphor (p)-ERK1/2, cAMP response element-binding protein (CREB), p-CREB and brain-derived neurotrophic
factor (BDNF) in the hippocampus were examined using western blot.
Results: Acupuncture ameliorated the depression-like behaviors and dysfunction of the ERK signaling pathway
in the hippocampus of CUMS rats. PD98059 pretreatment inhibited the improvements brought about by
acupuncture on the ERK signaling pathway.
Conclusions: Taken together, our results indicated that acupuncture had a significant antidepressant-like
effect on CUMS-induced depression model rats, and the ERK signaling pathway was implicated in this effect.
Keywords: Acupuncture, Depression, Extracellular signal-regulated kinase (ERK), Chronic unpredictable mild
stress (CUMS), Neurogenesis
Background
Depression is a common mental disorder and a leading
cause of disability throughout the world [1, 2]. Antide-
pressants remain the main clinical treatment for depres-
sion [3, 4]; however, antidepressants cannot completely
meet the needs of depression patients [5]. Acupuncture,
an important part of traditional Chinese medicine, has
been shown promising effects in alleviating the progres-
sion of depression [6, 7]. However, the underlying mech-
anism is poorly understood.
In the last few years, studies have found that a decline
in neurogenesis might be an etiological factor in depres-
sion [8, 9]. Brain-derived neurotrophic factor (BDNF)
has been shown to mediate neurogenesis and synaptic
plasticity, which is implicated in depression pathogenesis
[10]. The extracellular signal-regulated kinase (ERK) 1/2,
a downstream target of BDNF, is activated by the bind-
ing of BDNF to tyrosine kinase receptor-B (Trk-B) via
the Ras-dependent cascade, including phosphorylation
(p) of transcription factors such as cAMP response
element-binding protein (CREB) [11] (Fig. 1). Some
studies have proved that a decrease in ERK1/2 expres-
sion leads to depression-like behaviors in model rats
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[12–14]. Antidepressants can alleviate the symptoms of
depression by increasing ERK1/2 [15] and p-ERK1/2 ex-
pression [16–19].
Recent studies showed that acupuncture produced the
neuroprotective effects in many neurological disorders
[20], including up regulating the gene and protein ex-
pression of BDNF in hippocampus [21, 22], reducing
neural apoptosis and promoting adult neuron neurogen-
esis [23, 24]. Additionally, our previous study found that
acupuncture activated the proteins expression of phos-
phor (p)-ERK1/2 and p-CREB in the hippocampus and
prefrontal cortex in depression model rats [25]. There-
fore, we had a hypothesis that the antidepressant-like ef-
fect of acupuncture might via modulation of the ERK
signaling pathway [25, 26].
The aim of the present study was to investigate the
regulation of acupuncture on the depressive-like behav-
iors and the ERK signaling pathway as well as BDNF
protein expression in chronic unpredictable mild stress
(CUMS)-induced depression model rats. We used
PD98059 pretreatment to inhibit the activity of p-ERK1/
2; then, we evaluated the behavioral activities by the su-
crose intake and open field tests, as well as the protein
levels of ERK1/2, p-ERK1/2, CREB, p-CREB and BDNF
in the hippocampus by western blot analysis.
Methods
Animals
Eighty male Sprague–Dawley rats aged 8 weeks old and
weighing 180~200 g each were obtained from Vital River
Laboratory Animal Technology Co. Ltd, China (license
number SCXK [Jing] 2012-0001). The experimental pro-
cedures were conducted in compliance with the Guid-
ance Suggestions for the Care and Use of Laboratory
Animal, issued by the Ministry of Science and Technol-
ogy of China [27] and received approval from the Ani-
mal Ethics Committee of Beijing University of Chinese
Medicine (permission No. Kj-dw-18-20140923-01).
Overall research design
All animals were fed ad libitum, and housed at 23–25 °C
on a 12 h light/dark cycle (lights on between 7:00 A.M.
and 7:00 P.M.). They were randomly divided into eight
groups (n = 10 per group) as follows: (1) The control rats
were not subjected to any stress except general handling
for 3 weeks. (2) The CUMS group rats were exposed to
CUMS for 3 weeks. (3) The Acu group rats received
acupuncture stimulation and CUMS for 3 weeks. (4)
The FLX group rats received fluoxetine treatment and
CUMS for 3 weeks. (5) The DMSO group or (6)
PD98059 group (PD group) rats were exposed to CUMS
and intracerebroventricular injection of either dimethyl-
sulfoxide (DMSO) or PD98059, respectively, for 3 weeks.
Then, the groups in which PD98059 was administered
were treated in the same manner as the PD group except
(7) acupuncture (Acu + PD group) or (8) fluoxetine
(FLX + PD group) was also administered. One rat in the
Acu + PD group died during stereotactic surgery; thus,
79 rats were involved in the final analysis. The overall
research design is shown in Fig. 2.
Fig. 1 The ERK signaling pathway. BDNF combines with its specific receptor Trk-B and the compound object can activate the Ras-dependent cas-
cade. The Ras-dependent cascade is Ras-Raf-MEK-ERK signaling pathway. Phosphorylated ERK1/2 (p-ERK1/2) can further phosphorylate CREB and
promote the transcription of BDNF mRNA. PD98059 prevents the ERK1/2 from being phosphorylated. Activating reactions were depicted by an
arrow with a black color and the inhibiting effect of PD98059 was depicted by a line with a red color. The proteins involved in the present study
were marked by a rectangle box with a black color. BDNF brain-derived neurotrophic factor, CREB cAMP response element-binding protein, ERK1/2
extracellular signal-regulated kinase 1/2, MEK ERK1/2 kinase, p-CREB phosphor-CREB, p-ERK1/2 phosphor-ERK 1/2, Trk-B tyrosine receptor kinase B
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Fluoxetine is a classic antidepressant that belongs to se-
lective serotonin reuptake inhibitor medication. The recent
study demonstrated that fluoxetine-induced the increase in
BDNF protein level was accompanied by activating the
ERK signaling pathway [28]. So we chose fluoxetine as the
positive medication to evaluate the effect of acupuncture
on the ERK signaling pathway. PD98059 is dissolved in
DMSO to meet the concentration that can inhibit the ERK
signaling pathway [29, 30]. DMSO is characteristic of anti-
inflammation, analgesic and promoting blood circulation.
Besides, the placement of cannula is an invasive surgery.
So we set the DMSO group and compared it with the
CUMS and PD groups respectively to eliminate the inter-
ferences of DMSO and the surgery to the behavior tests
and the indexes.
Chronic unpredictable mild stress procedure
The chronic unpredictable mild stress (CUMS) model was
modified from the methods previously described [31] and
has been validate as one of the most relevant models of
depression. Except for the control group, all rats were ex-
posed to CUMS after 10 d of acclimatization under the
housing conditions. Seven different stressors were used to
model a state of depression as follows: food deprivation
(24 h), water deprivation (24 h), wet bedding (24 h), over-
night illumination (12 h), using a restraining device (2 h),
shaking the cage on a rocking bed (30 min), and clamping
the middle of tail with a binder clip (3 min). The CUMS
procedure was carried out for 3 weeks and a different
stressor was administered randomly each day.
Intracerebroventricular injection
Rats were anesthetized with 350 mg/kg 10 % chloral hy-
drate i.p. and placed in a rat brain stereotactic frame
(RWD, Shenzhen, China) with the incisor bar positioned
4 mm below the interaural zero. A burr hole (0.9 mm
posterior to the bregma; 1.5 mm lateral to the midline)
was drilled through the parietal bone and a stainless-
steel guide cannula (RWD; 0.58 mm outside diameter
[OD], 0.38 mm inside diameter [ID], 3.5 mm under the
dura [L]) was positioned in the lateral ventricle and se-
cured with screws and dental acrylic onto the skull, serv-
ing as a guide for the accurate insertion of a internal
cannula (RWD; 0.36 mm OD, 0.20 mm ID, aligning to
the tip of the guide cannula). A cap (RWD; 0.36 mm
diameter, aligning to the tip of the guide cannula) was
always placed in the guide cannula and removed during
the injection to prevent clogging or infection in the
brain tissue. Reflux of cerebrospinal fluid from the guide
cannula verified the correct placement of the intra-
cerebroventricular cannula. The rats were given 3 d to
recover after the surgery. After recovery, either 5 μL
PD98059 (100 μM, dissolved in DMSO) or 5 μL DMSO
was delivered by micro-injection with a pressure
equalizer tube connected to the internal cannula. After
injection, the internal cannula was left in the guide can-
nula for 1 min to ensure proper delivery.
Acupuncture and drug treatment
Acupuncture was performed at the acupoints of Baihui
(GV-20) and Yintang (GV-29) in Acu group and Acu +
PD group each day during the experimental procedure.
Sterilized disposable stainless steel needles of 0.3 mm
diameter were inserted as deep as 2–3 mm. GV-20 is lo-
cated above the apex auriculate, on the midline of the
head. GV-29 is located at the midpoint of the two eyes.
The acupuncture treatment was manually delivered by
twisting the acupuncture needles at a frequency of twice
Fig. 2 Overall research design
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per second for 1 min, and then the needles were
retained for 10 min [25]. The FLX group and FLX + PD
group were treated with 2.5 mg kg−1 d−1 fluoxetine
(intragastric administration) each day during the experi-
mental procedure.
Behavior tests
The sucrose intake test (SIT) is used as a measure of an-
hedonia [32]. Before the first SIT, the rats were habitu-
ated to consume 1 % sucrose solution for 24 h without
any water and then deprived of water for 24 h. The rats
were then given a 2-h window for SIT between 12:00
and 14:00 h. The amount of sucrose consumed was mea-
sured by comparing the bottle weight before and after
the 2-h window. The SIT was performed at beginning (0
d) and at end (21 d) of the experiment.
The open-field test (OFT) is commonly used to meas-
ure general locomotor activity and willingness to explore
in rodents [33]. In the OFT, the rat was gently placed at
the center of a square arena, which was a four-sided
80 × 80 × 40 cm3 box with the floor and walls painted
black. The arena was divided into 16 × 16 equal squares
that had been drawn on the floor. Each rat was allowed
to freely explore the arena for 5 min. The activity of the
rat was recorded by a video camera installed on top of
the lateral high wall, similar to our previous experiment
[34]. Two observers, blind to the experiment, counted
the crossing number (defined as at least three paws in a
square) and the rearing number (defined as the rat
standing upright on its hind legs). After each animal was
tested, the box was cleaned with a 10 % ethanol solution
to remove any olfactory cues. The OFT was also per-
formed at beginning (0 d) and at end (21 d) of the
experiment.
Western blotting analysis
Hippocampal tissue from rats was collected, immediately
placed on dry ice, and stored at −80 °C until assay. Sam-
ples were homogenized in a standard lysis buffer supple-
mented with protease or phosphatase inhibitor cocktail,
incubated on ice for 20 min, and centrifuged at
13,000 rpm for 20 min. The protein concentration was de-
termined using a bicinchoninic acid (BCA) protein assay
kit (Cwbio, Beijing, China). Proteins (24 μg) were sepa-
rated on a 10 % sodium dodecyl sulfate-polyacrylamide
gel electrophoresis gel (120 V, 60 min) and blotted
(300 mA, 100 min) onto a polyvinylidene fluoride mem-
brane. The membranes were blocked in 5 % bull serum al-
bumin (BSA) tris-buffered saline plus Tween (BSA-TBST)
for 1 h at room temperature (RT) and incubated at 4 °C
overnight with the following primary antibodies: anti-
ERK1/2 (catalogue NO.: 4965), anti-phosphor (p)-ERK1/2
(catalogue NO.: 4377), anti-response element binding pro-
tein (CREB) (catalogue NO.: 4820), anti-p-CREB
(catalogue NO.: 9198), and anti-BDNF (catalogue NO.:
ab46176) (1:1000 in 5 % BSA-TBST; Cell Signaling Tech-
nology, Danvers, MA, USA). Equal loading was confirmed
using anti-β-actin (catalogue NO.: TA-09) (1:1000 in 5 %
BSA-TBST; ZSGB-BIO, Beijing, China). Membranes were
washed with TBST and incubated for 60 min at RT with
horseradish peroxidase conjugated to goat anti-rabbit/
mouse IgG (catalogue NO.: 111-035-003/115-035-003)
(1:10,000 in 5 % BSA-TBST; Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, USA). Immunoreac-
tivity was visualized using enhanced chemiluminescence
(Merck Millipore, USA).
Statistical analysis
Data are presented as the mean ± SD. The comparisons
of sucrose intake and western blot analysis between
groups within the same time point were examined by
one-way analysis of variance (ANOVA) method after the
test of normal distribution and homogeneity of variance,
followed by the LSD post hoc test. Since the crossing
number and rearing number were not normally distrib-
uted, Kruskal-Wallis test was used, followed by the
Mann–Whitney U-test. Statistical significance was de-
fined as P < 0.05.
Results
Changes in sucrose intake
At the beginning (0 d), there was no significant differ-
ence among groups [F(7,71) = 0.862, P > 0.05]. At the end
of the experiment (21 d), the sucrose intake was signifi-
cantly different among groups [F(7,71) = 26.302, P < 0.01]
(Fig. 3 and Table 1). It was markedly reduced in the
CUMS group compared to that in the control group (P
< 0.01). Both acupuncture and fluoxetine treatment in-
creased the sucrose intake (P < 0.01 for both), and fluox-
etine treatment showed more effectiveness than
acupuncture in the sucrose intake test (P < 0.05). How-
ever, they were still lower than those in the control
group (P< 0.01 and P < 0.05, respectively). The difference
between the CUMS and DMSO groups was not signifi-
cant (P > 0.05), and the difference between the DMSO
and PD groups was also not significant (P > 0.05); how-
ever, the sucrose intake in the PD group was lower than
that in the CUMS group (P < 0.05). PD98059 pretreat-
ment obviously inhibited the increase induced by acu-
puncture or fluoxetine (P < 0.01 for both).
Comparison of crossing and rearing numbers
There was no significant difference among groups in
crossing [chi-square = 3.424, P > 0.05] (Fig. 4 and Table 2)
and rearing numbers [chi-square = 8.831, P > 0.05] (Fig. 5
and Table 2) at 0 d. After the 21-d stress procedure, the
crossing number (chi-square = 63.461, P < 0.01) (Fig. 4)
and rearing number [chi-square = 61.099, P < 0.01] (Fig. 5)
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differed significantly among groups. Compared to the con-
trol group, CUMS rats showed a significant reduction in
crossing and rearing numbers (P < 0.01 for both); however,
both acupuncture treatment and fluoxetine treatment im-
proved both crossing (P < 0.01 for both) and rearing num-
bers (P < 0.01 for both). There was no difference among
the CUMS, DMSO and PD groups in crossing (P > 0.05)
or rearing numbers (P > 0.05). The increase in rearing
numbers induced by both acupuncture and fluoxetine was
inhibited by PD98059 pretreatment (P < 0.01 for both);
however, the increase in crossing numbers induced by
acupuncture or fluoxetine was not affected by PD98059
pretreatment (P > 0.05 for both).
Western blot analysis of ERK1/2 and p-ERK1/2 in the
hippocampus
There was no significant difference in ERK1/2 protein
expression in the hippocampus [F(7,40) = 0.598, P > 0.05]
among the groups; however, p-ERK1/2 expression differ-
ent significantly among the groups [F(7,40) = 6.804, P <
0.01] (Fig. 6 and Table 3). The p-ERK1/2 levels were
down-regulated in the CUMS group (P < 0.01) compared
to that in the control group, and acupuncture or fluoxet-
ine treatment markedly increased these levels (P < 0.05
for both). The expression of p-ERK1/2 decreased more
in the PD group than that in the CUMS group (P < 0.05)
and the DMSO group (P < 0.01); however, there was no
difference between the CUMS and DMSO groups (P >
0.05). The expression of p-ERK1/2 in the Acu + PD
group was lower than that in the Acu group (P < 0.05).
There was no significant difference in p-ERK1/2 between
the FLX + PD and FLX groups, but the P value was close
to the critical point (P = 0.067).
Western blot analysis of CREB and p-CREB in the
hippocampus
There was a significant difference in CREB [F(7.40) = 3.323,
P < 0.01] and p-CREB [F(7,40) = 5.368, P < 0.01] expression
among the groups (Fig. 7 and Table 4). The expression of
both proteins was significantly down-regulated in the
CUMS group (P < 0.05 and P < 0.01, respectively) com-
pared to that in the control group. Acupuncture markedly
increased CREB and p-CREB protein expressions (P < 0.05
for both). Fluoxetine also increased CREB and p-CREB
protein expressions (P < 0.05 for both). There was no sig-
nificant difference in the expression of CREB (P > 0.05)
and p-CREB (P > 0.05) proteins among the CUMS, DMSO
and PD groups; however, CREB and p-CREB protein ex-
pressions in the Acu + PD group were lower than those in
the Acu group (P < 0.05 for both). Additionally, CREB and
p-CREB protein expressions in the FLX + PD group were
lower than those in the FLX group (P < 0.01 and P < 0.05,
respectively).
Western blot analysis of BDNF in the hippocampus
There was a significant difference in BDNF expression
among the groups [F(7.40) = 2.842, P < 0.05] (Fig. 8 and
Table 5). It was significantly down-regulated in the CUMS
group (P < 0.01) compared to that in the control group, and
acupuncture or fluoxetine treatment markedly increased
these levels (P < 0.05 for both). There was no significant dif-
ference in the expression of BDNF protein among the
CUMS, CUMS and PD groups (P > 0.05). Additionally, the
increase in BDNF protein induced by acupuncture or
Fig. 3 Sucrose intake at 0 d and 21 d. ★P < 0.05, ★★P < 0.01 versus control group; ▲P < 0.05, ▲▲P < 0.01 versus CUMS group; ◆P < 0.05, ◆◆P < 0.01
versus Acu group; ■■P < 0.01 versus FLX group. (mean ± SD, n = 9–10)
Table 1 Sucrose intake at 0 d and 21 d
Group Sucrose intake (g)
0 d 21 d
Control 25.96 ± 2.83 38.31 ± 6.63
CUMS 27.44 ± 3.68 22.17 ± 5.96★★
Acu 25.20 ± 2.77 28.49 ± 3.47★★▲▲
FLX 27.47 ± 4.29 33.51 ± 5.17★▲▲
DMSO 27.37 ± 3.95 18.35 ± 2.54
PD 27.77 ± 4.13 17.43 ± 3.96▲
Acu+PD 26.03 ± 3.02 18.15 ± 4.38◆◆
FLX+PD 25.37 ± 3.31 21.06 ± 5.10■■
★P < 0.05, ★★P < 0.01 vs. control group; ▲P < 0.05, ▲▲P < 0.01 vs. CUMS group;
◆◆P < 0.01 vs. Acu group; ■■P < 0.01 vs. FLX group. (mean ± SD, n = 9–10)
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fluoxetine was not affected by PD98059 pretreatment (P >
0.05 for both).
Discussion
Depression-like behaviors induced by CUMS
Chronic unpredictable mild stress (CUMS) can be used
as a valid and reliable method by which to build an ani-
mal model of depression [35–37]. There are various
methods to evaluate the model behaviors including the
sucrose intake test (SIT), the open-field test (OFT) and
the forced-swim test (FST). The decrease in sucrose
consumption is considered as the inhibition of the brain
reward system [38]. The OFT has been used widely to
assess the anxiety behaviors [39]; however, it also can be
used to evaluate the spontaneous activity in rodents [34,
40, 41]. Increased immobility in the FST is often anthro-
pomorphized as an expression of despair; however, it
can also be understood as a successful and adaptive be-
havioral response that functions to conserve energy [42].
Additionally, it was not recommended that the rats
which received the surgery to perform the FST. As a re-
sult, we chose the SIT and OFT to analyze the depres-
sive state of the model rats. The present study showed
that CUMS induced an obvious decrease in sucrose in-
take and locomotion. The results suggested that CUMS
decreased the sensitivity of model rats to sucrose and
exploration, which were similar to the depressive symp-
toms, such as anhedonia and behavioral and cognitive
dysfunction.
Chronic unpredictable mild stress made the hippocampal
extracellular signal-regulated kinase signaling pathway
dysfunction
The ERK signaling pathway participates in neural proli-
feration, differentiation and neurogenesis and plays an
important role in learning and memory [11, 43, 44]. A
growing body of study demonstrates that the ERK signal-
ing pathway is involved in the potential target for depres-
sion therapy [45–47], and inhibiting the ERK signaling
pathway can block antidepressant medications activities
[46, 48]. Furthermore, activated ERK protein can regulate
transcription by controlling the phosphorylation of cyclic
adenosine monophosphate response element binding
protein (CREB) [12], which mediates the transcription of
its target genes, such as BDNF mRNA and Bcl-2 mRNA.
An early study found that the expression of CREB and p-
CREB was decreased in the postmortem orbitofrontal
cortex of patients with major depression disorder [49].
Another study found that CRE-DNA complexes, CREB
protein, and CREB mRNA were reduced in the prefrontal
cortex of depression patients who committed suicide [50].
Therefore, CREB also plays an important role in the phy-
siology and pathology of depression [51] and treatment
with antidepressants [52]. However, our early study
showed that p-ERK1/2 and p-CREB, but not ERK1/2 and
CREB, proteins decreased in the hippocampus and pre-
frontal cortex of rats exposed to CUMS [25]. Thus, in the
present study, phosphorylated signaling proteins were
tested in conjunction with their counterparts. Interesting,
our finding showed that p-ERK1/2, CREB and p-CREB,
but not ERK1/2, proteins reduced in the hippocampus of
rats exposed to CUMS. It is known that only phos-
phorylated proteins exhibit full enzymatic activity; there-
fore, CUMS only reduced the expression of p-ERK1/2.
Nevertheless, the depression-like behaviors were associ-
ated with the reductions of both CREB and p-CREB in the
hippocampus.
Fig. 4 Crossing number at 0 d and 21 d. ★★P < 0.01 versus control group; ▲▲P < 0.01 versus CUMS group. (mean ± SD, n = 9–10)
Table 2 Numbers of crossing and rearing at 0 d and 21 d
Group Crossing number Rearing number
0 d 21 d 0 d 21 d
Control 66.2 ± 20.0 36.9 ± 7.8 18.4 ± 5.9 15.0 ± 5.2
CUMS 73.3 ± 17.6 4.7 ± 2.1★★ 13.5 ± 2.3 2.5 ± 1.7★★
Acu 64.4 ± 18.0 15.0 ± 5.1★★▲▲ 14.8 ± 3.7 8.9 ± 2.5▲▲
FLX 68.5 ± 19.1 16.9 ± 6.0★★▲▲ 15.9 ± 3.8 9.5 ± 2.1▲▲
DMSO 64.9 ± 18.6 3.8 ± 2.3 14.3 ± 3.6 1.5 ± 1.4
PD 62.2 ± 18.8 4.1 ± 2.9 12.8 ± 3.0 1.4 ± 1.3
Acu+PD 69.0 ± 18.0 17.0 ± 5.5 14.3 ± 3.1 4.2 ± 2.0◆◆
FLX+PD 60.4 ± 20.8 18.7 ± 7.2 13.4 ± 3.9 3.7 ± 2.2■■
★★P < 0.01 vs. control group; ▲▲P < 0.01 vs. CUMS group; ◆◆P < 0.01 vs. Acu
group; ■■P < 0.01 vs. FLX group. (mean ± SD, n = 9–10)
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Effect of CUMS on expression of BDNF protein in the
hippocampus
Previous studies have confirmed that hippocampal
neurogenesis plays an important role in cognitive and
emotional control [53] and that an increase in neural
apoptosis can lead to mental disorders [54]. Addition-
ally, a recent study gave direct evidence that the de-
creased neurogenesis was implicated in the pathogenesis
of anxiety and depression [55]. Furthemore, research in-
creasingly suggests that antidepressants can promote
hippocampal neuron proliferation and differentiation
[56–60]. BDNF is associated with neuroprotective and syn-
aptic plasticity in the central nervous system [61], especially
in the hippocampus [62, 63]. An early study proved that a
reduction in BDNF in the hippocampus affects several be-
haviors related to depression [64]. Consistent with the
previous studies, our results showed that the expression of
BDNF protein decreased in rats exposed to CUMS, which
demonstrated that the depression-like behaviors induced by
CUMS were associated with BDNF protein in the hippo-
campus. Moreover, BDNF protein can activate the ERK sig-
naling pathway by combining with its specific receptor
tyrosine receptor kinase-B (Trk-B) [11]. Thus, reduction of
BDNF protein might lead to a negative feedback to the
ERK signaling pathway.
Effect of PD98059 pretreatment on the behavior of CUMS
rats and the ERK signaling pathway
Intracerebroventricular injection of PD98059, an inhibitor
of ERK1/2, had no marked effect on the OFT and the
expression of ERK1/2, CREB, p-CREB and BDNF in model
rats; however, PD98059 pretreatment aggravated the
Fig. 5 Rearing number at 0 d and 21 d. ★★P < 0.01 versus control group; ▲▲P < 0.01 versus CUMS group; ◆◆P < 0.01 versus Acu group; ■■P < 0.01
versus FLX group. (mean ± SD, n = 9–10)
Fig. 6 Western blot analysis of ERK1/2 and p-ERK1/2. a The representative immunoblot made from hippocampal tissue of rats. b The quantifica-
tion of ERK1/2/β-actin ratio levels. c The quantification of p-ERK1/2/β-actin ratio levels. ★★P < 0.01 vs. control group; ▲P < 0.05 vs. CUMS group;
▼▼P < 0.01 vs. DMSO group; ◆P < 0.05 vs. Acu group. (mean ± SD, n = 6)
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decrease in the sucrose intake and the expression of p-
ERK1/2 protein compared to those in the CUMS or DMSO
group. The results were consistent with the property of
PD98059 that prevents ERK1/2 from being phosphorylated
without affecting the total protein, and suggested that inhibit-
ing the expression of p-ERK1/2 protein in the hippocampus
might lead to anhedonia. Additionally, there was no signifi-
cant difference between the CUMS and DMSO groups in
the SITand OFTas well as the expressions of above proteins,
which eliminated the disturbance of the surgery and DMSO.
Acupuncture ameliorated depression-like behaviors and
activated the ERK signaling pathway in the hippocampus
Acupuncture has been extensively used to treat depression
in East Asian countries and has exhibited effective results
in clinics. According to traditional Chinese medicine, Bai-
hui (GV-20) and Yintang (GV-29) are points pertaining to
Governor Meridian [34] and Governor Meridian has a dir-
ect contact with brain through channels and collaterals
[41]. Thus, the acupoints of Baihui (GV-20) and Yintang
(GV-29) are commonly used for treating depression [65].
In early studies, stimulation at Baihui (GV-20) and Yin-
tang (GV-29) with electro-acupuncture (EA) exhibited
antidepressant-like efficacy on in the SIT and OFT [34,
41]. In the present study, manual acupuncture performed
at these acupoints also increased sucrose intake in the SIT
and numbers of crossing and rearing in the OFT com-
pared to the model rats, which proved that acupoint spe-
cificity can also play a significant role, independent of the
electrical stimulus [25, 66, 67]. However, acupuncture was
not as effective as fluoxetine in increasing sucrose intake in
our study. In animals, the administration of acupuncture
treatment is also a stimulation that is not as controllable as
intragastric injection administration of a drug. Although
the acupuncture has no effect on rats having a normal
physiological state [25], the stimulation might influence the
antidepressant-like effects of acupuncture on CUMS rats.
In the last few years, some studies indicated that the ERK
signaling pathway was implicated in the antidepressant-like
effects of acupuncture (manual acupuncture or EA). We
previous found that manual acupuncture stimulation at
Baihui (GV-20) and Neiguan (PC-6) increased the ratio of
p-ERK1/2 to ERK1/2 and the ratio of p-CREB to CREB in
the hippocampus and prefrontal cortex in CUMS rats [25].
Table 3 Western blot analysis of ERK1/2 and p-ERK1/2
Group ERK1/2/β-actin p-ERK1/2/β-actin
Control 0.573 ± 0.101 0.350 ± 0.040
CUMS 0.512 ± 0.108 0.264 ± 0.041★★
Acu 0.515 ± 0.073 0.332 ± 0.046▲
FLX 0.546 ± 0.104 0.333 ± 0.036▲
DMSO 0.505 ± 0.107 0.301 ± 0.045
PD 0.508 ± 0.089 0.185 ± 0.069▲▼▼
Acu+PD 0.502 ± 0.059 0.255 ± 0.060◆
FLX+PD 0.480 ± 0.077 0.278 ± 0.059
★★P < 0.01 vs. control group; ▲P < 0.05 vs. CUMS group; ▼▼P < 0.01 vs. DMSO
group; ◆P < 0.05 vs. Acu group. (mean ± SD, n = 6)
Fig. 7 Western blot analysis of CREB and p-CREB. a The representative immunoblot made from hippocampal tissue of rats. b The quantification
of CREB/β-actin ratio levels. c The quantification of p-CREB/β-actin ratio levels. ★P < 0.05, ★★P < 0.01 vs. control group; ▲P < 0.05 vs. CUMS group;
◆P < 0.05 vs. Acu group; ■P < 0.05, ■■P < 0.01 vs. FLX group. (mean ± SD, n = 6)
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In addition, Liu et al. showed that EA stimulation at Baihui
(GV-20) and Yang-ling-quan (GB-34) mitigated depressive-
like behaviors through increasing the p-ERK1/2 level in the
hippocampus [26]. One research also found that EA stimu-
lation at Baihui (GV-20) and Yintang (GV-29) acted on de-
pression by enhancing the p-ERK1/2 in the hippocampus
[68]. In the present study, we found that manual acupunc-
ture performed at acupoints of Baihui (GV-20) and Yintang
(GV-29) increased levels of p-ERK1/2, CREB, and p-CREB
in the hippocampus. Pretreatment with PD98059 inhibited
these improvements as well as the increase in sucrose in-
take and numbers of crossing and rearing. These results
provided the direct evidence that the ERK signaling path-
way was involved in the antidepressant-like effects of
acupuncture.
Effect of acupuncture on the expression of BDNF protein
in the hippocampus
Recent research on depression focuses on neuroprotec-
tion, and an increasing number of studies support the
notion that acupuncture is a rescuer of impaired neuro-
genesis [69]. It has been reported that acupuncture acts
on depression by enhancing neuropeptide Y (NYP) in
the hypothalamus [70] and amplifying neural progenitors
(ANPs) proliferation, as well as preserving quiescent
neural progenitors (QNPs) from apoptosis [71]. In our
study, acupuncture markedly increased BDNF protein
level, which provided further evidence to support the
positive results. An early study found that inhibiting
ERK1/2 phosphorylation can block the antidepressant-
like consequences produced by infusing BDNF into the
dentate gyrus [72]. Thus, we speculated that the ERK
signaling pathway was implicated in acupuncture’s regu-
lation of BDNF protein; however, the results showed that
pretreatment with PD98059 did not abolish the effect of
acupuncture on the BDNF protein. It is well known that
CREB is an intersection of several signaling pathways. In
addition to the ERK signaling pathway, cAMP-PKA and
Ca2+/CaMK can also phosphorylate CREB and promote
the transcription of BDNF mRNA. So an inhibited ERK
signaling pathway can not suppress acupuncture on the
regulation of BDNF protein. In addition, acupuncture’s
neuroprotective effects may associate with the enhance-
ment of p-p38 [68] and inhibition of pro-inflammatory
cytokines [34, 73] and NF-kB signaling pathway [74] in
the hippocampus. Moreover, in our previous study, it
was found that acupuncture decreased the protein ex-
pressions of phosphor-Jun N-terminal kinase (p-JNK)
and c-Jun, two important proteins in the JNK signaling
pathway, and inhibited neural apoptosis mediated by
caspases (data not published). Thus, the ERK signaling
pathway is involved in the effects of acupuncture on
neurotrophy and neurogenesis. However, the neuropro-
tective effect of acupuncture is not limited to the ERK
signaling pathway.
Conclusions
In conclusion, the present study demonstrated that
depression-like behaviors of rats induced by CUMS were
associated with the dysfunction of the ERK signaling
pathway in the hippocampus. Importantly, our findings
Table 4 Western blot analysis of CREB and p-CREB
Group CREB/β-actin p-CREB/β-actin
Control 0.434 ± 0.045 0.367 ± 0.053
CUMS 0.371 ± 0.039★ 0.261 ± 0.092★★
Acu 0.427 ± 0.037▲ 0.344 ± 0.042▲
FLX 0.423 ± 0.055▲ 0.345 ± 0.036▲
DMSO 0.394 ± 0.022 0.259 ± 0.061
PD 0.419 ± 0.030 0.198 ± 0.072
Acu+PD 0.371 ± 0.041◆ 0.270 ± 0.063◆
FLX+PD 0.345 ± 0.065■■ 0.272 ± 0.043■
★P < 0.05, ★★P < 0.01 vs. control group; ▲P < 0.05 vs. CUMS group; ◆P < 0.05 vs.
Acu group; ■P < 0.05, ■■P < 0.01 vs. FLX group. (mean ± SD, n = 6)
Fig. 8 Western blot analysis of BDNF. a The representative
immunoblot made from hippocampal tissue of rats. b The
quantification of BDNF/β-actin ratio levels. ★★P < 0.01 vs. control
group; ▲P < 0.05 vs. CUMS group. (mean ± SD, n = 6)
Table 5 Western blot analysis of BDNF
Group BDNF/β-actin
Control 0.334 ± 0.076
CUMS 0.217 ± 0.018★★
Acu 0.301 ± 0.066▲
FLX 0.319 ± 0.069▲
DMSO 0.222 ± 0.043
PD 0.231 ± 0.054
Acu+PD 0.245 ± 0.088
FLX+PD 0.250 ± 0.090
★★P < 0.01 vs. control group; ▲P < 0.05 vs. CUMS group. (mean ± SD, n = 6)
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indicated that acupuncture treatment effectively miti-
gated depressive behaviors and the ERK signaling path-
way was involved in the antidepressant-like effects of
this treatment.
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